Reported Reactions

Devices › Device types

FDA product code PFO · class 2 · Ear, Nose, Throat

Active implantable bone conduction hearing system: medical device reports filed with FDA

3,471 reports carry this product code, 2018–2026; 9 brands with a page.

3,471
reports with this product code
0% of all MAUDE reports
969
reports, 12 months to August 2026
928 in the 12 months before
10.7%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

Product code PFO is FDA's classification for "Active implantable bone conduction hearing system" (ear, Nose, Throat panel), a class 2 device. 3,471 medical device reports carry this product code, 0% of the MAUDE database, from October 2018 to August 2026.

969 reports arrived in the 12 months to August 2026, close to the 928 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (89.3%) and malfunction (10.7%). 9 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Cochlear Osia OSI200 Implant1,7362470.1%3.8%
Cochlear Osia OSI300 Implant1,0895400%1.8%
Bonebridge385990%64.9%
Asku622101.1%47.1%
Nucleus CI522 Cochlear Implant with Slim Straight Electrode21790%13.1%
Nucleus CI422 Cochlear Implant with Slim Straight Electrode1520%13.4%
Nucleus CI512 Cochlear Implant with Contour Advance Electrode12320%25.6%
Nucleus CI532 Cochlear Implant with Slim Modiolar Electrode1820%12.6%
Nucleus CI622 Cochlear Implant with Slim Straight Electrode15100%4.9%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Cochlear3,01586.9%
Med-El Elektromedizinische Geraete40511.7%
Cochlear Bone Anchored Solutions581.7%
Oticon Medical361%

Reports by month, five years

057114Sep 2021: 15Oct 2021: 25Nov 2021: 15Dec 2021: 362022Jan 2022: 23Feb 2022: 15Mar 2022: 15Apr 2022: 17May 2022: 22Jun 2022: 28Jul 2022: 30Aug 2022: 19Sep 2022: 24Oct 2022: 34Nov 2022: 48Dec 2022: 312023Jan 2023: 26Feb 2023: 33Mar 2023: 44Apr 2023: 35May 2023: 26Jun 2023: 49Jul 2023: 49Aug 2023: 41Sep 2023: 58Oct 2023: 51Nov 2023: 34Dec 2023: 272024Jan 2024: 53Feb 2024: 34Mar 2024: 58Apr 2024: 63May 2024: 86Jun 2024: 59Jul 2024: 59Aug 2024: 49Sep 2024: 87Oct 2024: 65Nov 2024: 51Dec 2024: 482025Jan 2025: 65Feb 2025: 114Mar 2025: 54Apr 2025: 110May 2025: 64Jun 2025: 79Jul 2025: 90Aug 2025: 101Sep 2025: 92Oct 2025: 80Nov 2025: 86Dec 2025: 732026Jan 2026: 74Feb 2026: 110Mar 2026: 91Apr 2026: 85May 2026: 73Jun 2026: 81Jul 2026: 90Aug 2026: 34

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0%1
Injury89.3%3,099
Malfunction10.7%370
Other0%1
Not given0%0

Who filed

Manufacturer report62.2%2,159
Voluntary report0.2%6
User facility report0%0
Distributor report37.6%1,304
Not given0.1%2

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Expulsion77922.4%
No device output2136.1%
Insufficient device problem information1714.9%
Device dislodged or dislocated932.7%
Output problem822.4%
Device appears to trigger rejection812.3%
Unexpected therapeutic results651.9%
Inadequacy of device shape and/or size511.5%
Patient device interaction problem471.4%
Therapeutic or diagnostic output failure381.1%
Loss of osseointegration331%
Signal artifact/noise310.9%
Failure to deliver shock/stimulation220.6%
Failure to read input signal220.6%
Loose or intermittent connection210.6%
Noise, audible170.5%
Improper or incorrect procedure or method160.5%
Migrationthe device moved from where it was placed160.5%
Malposition of device140.4%
Device handling problem130.4%

Questions about active implantable bone conduction hearing system reports

What is product code PFO?

FDA's classification code for "Active implantable bone conduction hearing system", class 2, reviewed by the ear, Nose, Throat panel. Every device report carries the product code of the device involved.

How many reports carry this code?

3,471 reports through August 2026, 969 of them in the latest 12 months.

Which brands appear most often?

Cochlear Osia OSI200 Implant (1,736), Cochlear Osia OSI300 Implant (1,089), Bonebridge (385), Asku (62) and Nucleus CI522 Cochlear Implant with Slim Straight Electrode (2). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.